Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High Burden of Obesity and Low Rates of Weight Loss Pharmacotherapy in Inflammatory Bowel Disease: 10-Year Trend
Abbinaya Elangovan, Raj Shah, Sajjadh M. J. Ali, et al.
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 14

Showing 14 citing articles:

Heavy arch: from inflammatory bowel diseases to metabolic disorders
Timon E. Adolph, Moritz Meyer, A Jukic, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1376-1387
Open Access | Times Cited: 14
Review article: Evidence‐based dietary management of inflammatory bowel disease
Peter R. Gibson, Chu K Yao, Emma P. Halmos
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1215-1233
Open Access | Times Cited: 9
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity
Aakash Desai, Himsikhar Khataniar, Jana G. Hashash, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 6
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management
Wissam Ghusn, Edward V. Loftus, Amanda M. Johnson
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 268-275
Closed Access | Times Cited: 5
Impact of Obesity and Metabolic Syndrome on IBD Outcomes
Maya Mahmoud, Wing-Kin Syn
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 8, pp. 2741-2753
Closed Access | Times Cited: 5
Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED)
Eugeni Domènech, Andreea Ciudin, José M. Balibrea, et al.
Gastroenterología y Hepatología (2024) Vol. 47, Iss. 8, pp. 906-923
Open Access | Times Cited: 4
GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN
Yuri Gorelik, Itai Ghersin, Rona Lujan, et al.
Journal of Crohn s and Colitis (2024)
Open Access | Times Cited: 2
Does cardiovascular risk matter in IBD patients?
Herbert Tilg, Mathurin Fuméry, Charlotte Hedin
Journal of Internal Medicine (2023) Vol. 294, Iss. 6, pp. 708-720
Open Access | Times Cited: 6
Preoperative optimization: Review on nutritional assessment and strategies in IBD
J Vanderstappen, Sien Hoekx, Gabriele Bislenghi, et al.
Current Opinion in Pharmacology (2024) Vol. 77, pp. 102475-102475
Closed Access | Times Cited: 1
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD
Irving Levine, Shaina Sekhri, William Schreiber-Stainthorp, et al.
Inflammatory Bowel Diseases (2024)
Closed Access | Times Cited: 1
Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)
Eugeni Domènech, Andreea Ciudin, José M. Balibrea, et al.
Gastroenterología y Hepatología (English Edition) (2024) Vol. 47, Iss. 8, pp. 906-923
Open Access
Efficacy and Safety of Glp-1 Agonists on Metabolic Parameters in Non-diabetic Patients With Inflammatory Bowel Disease
Joëlle St‐Pierre, Jeremy Klein, Natalie K. Choi, et al.
Research Square (Research Square) (2024)
Open Access
Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease
Joëlle St‐Pierre, Jeremy Klein, Natalie K. Choi, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 12, pp. 4437-4445
Closed Access
Editorial: Pharmacotherapy for Obesity in Persons With Inflammatory Bowel Disease
James Stone, Wael El‐Matary
Crohn s & Colitis 360 (2023) Vol. 5, Iss. 2
Open Access
Page 1

Scroll to top